News
Hosted on MSN4mon
Duloxetine Recall: FDA Sets Second-Highest Risk Level for Antidepressants Containing Potential CarcinogenCertain bottles and doses of duloxetine, a common antidepressant, have been recalled due to the presence of potentially cancer-causing chemicals. The recall was initiated on Nov. 19 by ...
For diabetic peripheral neuropathic pain, the recommended dosage is 60 mg per day, although dosages ... increase the risk of adverse effects. In duloxetine studies for any indication, there ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results